The results showed that high CLIC6 promoter methylation was a protective factor associated with better outcomes in LGG patients; it was an adverse factor associated with poorer OS and DSS in ACC patients (P < 0.05, Supplementary Figure S4E). This evidence concerns the gene CLIC6 and adrenal cortex carcinoma.